Jawad Ahmad, MD
- PROFESSOR | Medicine, Liver Diseases
Specialties:Liver Medicine, Liver Transplantation
Research Topics:Liver, Transplantation
Dr. Ahmad graduated with his medical degree with honors from the Royal Free Hospital School of Medicine, University of London. He completed post-graduate internal medicine training in the United Kingdom. He completed internal medicine and chief residency at the State University of New York at Stony Brook and gastroenterology and hepatology fellowship at the University of Pittsburgh. He previously served as the Chief of the GI Section at the Veterans’ Affairs Pittsburgh Healthcare System and was Co-Medical Director of Transplant Hepatology at the Thomas E. Starzl Transplantation Institute in Pittsburgh. Dr. Ahmad has published widely in the fields of hepatology and transplant hepatology. His main research interests include organ allocation and recurrent disease after liver transplantation.
American Board of Internal Medicine
MD, Royal Free Hospital Sch of Medicine
Residency, Internal Medicine, SUNY at Stony Brook School of Medicine
Fellowship, Gastroenterology & Hepatology, University of Pittsburgh Medical Center
Dr Jawad Ahmad is co Primary Investigator on NIH/NIDDK research initiative to study cases of severe liver injury caused by caused by prescription drugs, over-the-counter drugs, and alternative medicines, such as herbal products and supplements. For more information on the Drug-Induced Liver Injury Network (DILIN) visit: https://dilin.dcri.duke.edu/
- A Phase 2 Proof of Concept Study Investigating the Preliminary Efficacy and Safety of Cenicriviroc in Adult Subjects with Primary Sclerosing Cholangitis (PSC)
The purpose of this study is to look at the safety and effectiveness of the study drug cenicriviroc (CVC) and how well it works for the treatment of Primary Sclerosing Cholangitis (PSC). CVC is an investigational drug. This means that CVC is still being studied. It also means ...
Ahmad J, Eng FJ, Branch AD. HCV and HCC: Clinical Update and a Review of HCC-Associated Viral Mutations in the Core Gene. Seminars in liver disease 2011 Nov; 31(4).
Sundaram V, Jones DT, Shah NH, de Vera ME, Fontes P, Marsh JW, Humar A, Ahmad J. Posttransplant biliary complications in the pre- and post-model for end-stage liver disease era. Liver transplantation 2011 Apr; 17(4).
Mounzer R, Malik SM, Nasr J, Madani B, Devera ME, Ahmad J. Spontaneous bacterial peritonitis before liver transplantation does not affect patient survival. Clinical gastroenterology and hepatology 2010 Jul; 8(7).
Malik SM, Devera ME, Fontes P, Shaikh O, Sasatomi E, Ahmad J. Recurrent disease following liver transplantation for nonalcoholic steatohepatitis cirrhosis. Liver transplantation 2009 Dec; 15(12).
Malik SM, deVera ME, Fontes P, Shaikh O, Ahmad J. Outcome after liver transplantation for NASH cirrhosis. American journal of transplantation 2009 Apr; 9(4).
Malik SM, Gupte PA, de Vera ME, Ahmad J. Liver transplantation in patients with nonalcoholic steatohepatitis-related hepatocellular carcinoma. Clinical gastroenterology and hepatology 2009 Jul; 7(7).